Ligand stabilization of CXCR4/δ-opioid receptor heterodimers reveals a mechanism for immune response regulation

European Journal of Immunology

Volumn 38, Issue 2, 2008, Pages 537-549

  Pello, Oscar M ^a   Martínez Muñoz, Laura ^a   Parrillas, Verónica ^a   Serrano, Antonio ^b   Rodríguez Frade, José Miguel ^a   Toro, María José ^c   Lucas, Pilar ^a   Monterrubio, María ^a   Martínez A, Carlos ^a   Mellado, Mario ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Chemokine receptor; GPCR oligomerization; Opioid receptors

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; DELTA OPIATE RECEPTOR; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; G PROTEIN COUPLED RECEPTOR; HETERODIMER; STROMAL CELL DERIVED FACTOR 1; CXCL12 PROTEIN, MOUSE; LIGAND; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVATION; ENZYME REPRESSION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; MOLECULAR MODEL; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; DIMERIZATION; DRUG ANTAGONISM; LEUKEMIA CELL LINE; LEUKOCYTE MIGRATION INHIBITION TEST; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

CELL ADHESION; CELL LINE, TUMOR; CELL MIGRATION INHIBITION; CHEMOKINE CXCL12; DIMERIZATION; ENKEPHALIN, D-PENICILLAMINE (2,5)-; HUMANS; JURKAT CELLS; LIGANDS; RECEPTORS, CXCR4; RECEPTORS, OPIOID, DELTA;

EID: 42249106416     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200737630     Document Type: Article

References (55)

1. Bockaert, J. and Pin, J. P., Molecular tinkering of G protein-coupled receptors: An evolutionary success. EMBO J. 1999, 18: 1723-1729.
2. Gomes, L, Filipovska, J., Jordan, B. A. and Devi, L A., Oligomerization of opioid receptors. Methods 2002. 27: 358-365.
3. Jordan, B. A., Cvejic, S. and Devi, L. A., Opioids and their complicated receptor complexes. Neuropsychopharmacology 2000. 23: S5-S18.
4. Angers, S., Salahpour, A. and Bouvier, M., Biochemical and biophysical demonstration of GPCR oligomerization in mammalian cells. Life Sci. 2001. 68: 2243-2250.
5. Devi, L. A., Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol. Sci. 2001. 22: 532-537.
6. Terrillon, S. and Bouvier, M., Roles of G-protein-coupled receptor dimerization. EMBO Rep. 2004. 5: 30-34.
7. McCarthy, L., Wetzel, M., Sliker, J. K., Eisenstein, T. K. and Rogers, T. J., Opioids, opioid receptors, and the immune response. Drug Alcohol Depend. 2001. 62: 111-123.
8. Chen, C., Li, J., Bot, G., Szabo, I., Rogers, T. J. and Liu-Chen, L. Y., Heterodimerization and cross-desensitization between the mu-opioid receptor and the chemokine CCR5 receptor. Eur. J. Pharmacol. 2004. 483: 175-186.
9. Steele, A. D., Szabo, I., Bednar, F. and Rogers, T. J., Interactions between opioid and chemokine receptors: Heterologous desensitization. Cytokine Growth Factor Rev. 2002. 13: 209-222.
10. Szabo, I., Wetzel, M. A., Zhang, N., Steele, A. D., Kaminsky, D. E., Chen, C., Liu-Chen, L. Y. et al., Selective inactivation of CCR5 and decreased infectivity of R5 HIV-1 strains mediated by opioid-induced heterologous desensitization. J. Leukoc. Biol. 2003. 74: 1074-1082.
11. Pello, O. M., Duthey, B., García-Bernal, D., Rodríguez-Frade, J. M., Stein, J. V.. Teixidó, J., Martínez-A, C. et al., Opioids trigger alpha 5 beta 1 integrin-mediated monocyte adhesion. J. Immunol. 2006. 176: 1675-1685.
12. Miyagi, T., Chuang, L. F., Lam, K. M., Kung, H., Wang, J. M.., Osburn, B. I. and Chuang, R. Y., Opioids suppress chemokine-mediated migration of monkey neutrophils and monocytes - an instant response. Immunopharmacology 2000. 47: 53-62.
13. Rossi, D. and Zlotnik, A., The biology of chemokines and their receptors. Ann. Rev. Immunol. 2000. 18: 217-242.
14. Bleul, C. C., Fuhlbrigge, R. C., Casasnovas, J. M., Aiuti, A. and Springer, T. A., A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) J. Exp. Med. 1996. 184: 1101-1109.
15. Lapidot, T. and Kollet, O., The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 2002. 16: 1992-2003.
16. Nagasawa, T., Hirota, S., Tachibana, K., Takakura, N., Nishikawa, S., Kitamura, Y., Yoshida, N. et al., Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996. 382: 635-638.
17. Zou, Y. R., Kottmann, A. H., Kuroda, M., Taniuchi, I. and Littman, D. R., Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998. 393: 595-599.
18. Moonis, M., Lee, B., Bailer, R. T., Luo, Q. and Montaner, L. J., CCR5 and CXCR4 expression correlated with X4 and R5 HIV-1 infection yet not sustained replication in Th1 and Th2 cells. AIDS 2001. 15: 1941-1949.
19. Lusso, P., HIV and the chemokine system: 10 years later. EMBO J. 2006. 25: 447-456.
20. Muller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T. et al., Involvement of chemokine receptors in breast cancer metastasis. Nature 2001. 410: 50-56.
21. Zlotnik, A., Chemokines in neoplastic progression. Semin. Cancer Biol. 2004. 14: 181-185.
22. Vila-Coro, A. J., Rodríguez-Frade, J. M., Martín de Ana, A., Moreno-Ortiz, M. C., Martínez-A, C. and Mellado, M., The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway. FASEB J. 1999. 13: 1699-1710.
23. Soriano, S. F., Serrano, A., Hernanz-Falcón, P., Martín de Ana, A., Monterrubio, M., Martínez-A, C., Rodríguez-Frade, J. M. et al., Chemokines integrate JAK/STATand G-protein pathways during chemotaxis and calcium flux responses. Eur. J. Immunol. 2003. 33: 1328-1333.
24. Thelen, M., Dancing to the tune of chemokines. Nat. Immunol. 2001. 2: 129-134.
25. Quock, R. M., Hosohata, Y., Knapp, R. J., Burkey, T. H., Hosohata, K., Zhang, X., Rice, K. C. et al., Relative efficacies of delta-opioid receptor agonists at the cloned human delta-opioid receptor. Eur. J. Pharmacol. 1997. 326: 101-104.
26. Belcheva, M.M., Vogel, Z., Ignatova, E., Avidor-Reiss, T., Zippel, R., Levy, R., Young, E. C. et al., Opioid modulation of extracellular signal-regulated protein kinase activity is ras-dependent and involves Gbetagamma subunits. J. Neurochem. 1998. 70: 635-645.
27. Eisinger, D. A. and Schulz, R., Extracellular signal-regulated kinase/mitogen-activated protein kinases block internalization of delta-opioid receptors. J. Pharmacol. Exp. Ther. 2004. 309: 776-785.
28. Lee, J. W., Joshi, S., Chan, J. S. and Wong, Y. H., Differential coupling of mu-, delta-, and kappa-opioid receptors to G alpha16-mediated stimulation of phospholipase C. J. Neurochem. 1998. 70: 2203-2211.
29. Sharp, B. M., Shahabi, N. A., Heagy, W., McAllen, K., Bell, M., Huntoon, C. and McKean, D. J., Dual signal transduction through delta opioid receptors in a transfected human T-cell line. Proc. Natl. Acad. Sci. USA 1996. 93: 8294-8299.
30. Noble, F. and Cox, B. M., Differences among mouse strains in the regulation by mu, delta 1 and delta 2 opioid receptors of striatal adenylyl cyclases activated by dopamine D1 or adenosine A2a receptors. Brain Res. 1996. 716: 107-117.
31. Bleul, C. C., Wu, L., Hoxie, J. A., Springer, T. A. and Mackay, C. R., The HIV corecptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 1997. 94: 1925-1930.
32. Sharp, B. M., Multiple opioid receptors on immune cells modulate intracellular signaling. Brain Behav. Immun. 2006. 20: 9-14.
33. Balabanian, K., Lagane, B., Infantino, S., Chow, K. Y., Harriague, J., Moepps, B., Arenzana-Seisdedos, F. et al., The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J. Biol. Chem. 2005. 280: 35760-35766.
34. Ming, J. M., Bersani, L. and Mantovani, A., Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes. J. Immunol. 1987. 138:1469-1474.
35. Huttenrauch, F., Pollok-Kopp, B. and Oppermann, M., G protein-coupled receptor kinases promote phosphorylation and beta-arrestin-mediated internalization of CCR5 homo- and hetero-oligomers. J. Biol. Chem. 2005. 280: 37503-37515.
36. Wentworth, J. K., Pula, G. and Poole, A. W., Vasodilator-stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C-dependent and -independent mechanisms in thrombin-stimulated human platelets. Biochem. J. 2006. 393: 555-564.
37. Gomes, I., Filipovska, J. and Devi, L. A., Opioid receptor oligomerization. Detection and functional characterization of interacting receptors. Methods Mol. Med. 2003. 84: 157-183.
38. Percherancier, Y., Berchiche, Y. A., Slight, I., Volkmer-Engert, R., Tamamura, H., Fujii, N., Bouvier, M. et al., Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers. J. Biol. Chem. 2005. 280: 9895-9903.
39. Quock, R. M., Burkey, T. H., Varga, E., Hosohata, Y., Hosohata, K., Cowell, S. M., Slate, C. A. et al., The delta-opioid receptor: molecular pharmacology, signal transduction, and the determination of drug efficacy. Pharmacol. Rev. 1999. 51: 503-532.
40. Vaughn, L. K., Knapp, R. J., Toth, G.,Wan, Y. P., Hruby, V. J., Henry, I. and Yamamura, H. L., A high affinity, highly selective ligand for the delta opioid receptor: [3H]-[D-Pen2, pCl-Phe4, d-Pen5]enkephalin. Life Sci. 1989. 45: 1001-1008.
41. + murine T cells. J. Pharmacol. Exp. Ther. 1995. 273: 1105-1113.
42. Kohout, T. A., Nicholas, S. L., Perry, S. J., Reinhart, G., Junger, S. and Struthers, R. S., Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7. J. Biol. Chem. 2004. 279: 23214-23222.
43. Gomes, I., Jordan, B. A., Gupta, A., Trapaidze, N., Nagy, V. and Devi, L. A., Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. J. Neurosci. 2000. 20: RC110.
44. Di Salvo, J., Koch, G. E., Johnson, K. E., Blake, A. D., Daugherty, B. L., DeMartino, J. A., Sirotina-Meisher, A. et al., The CXCR4 agonist ligand stromal derived factor-1 maintains high affinity for receptors in both Galpha(i)-coupled and uncoupled states. Eur. J. Pharmacol. 2000. 409: 143-154.
45. Doranz, B. J., Orsini, M. J., Turner, J. D., Hoffman, T. L., Berson, J. F., Hoxie, J. A., Peiper, S. C. et al., Identification of CXCR4 domains that support coreceptor and chemokine receptor functions. J. Virol. 1999. 73: 2752-2761.
46. Mellado, M., Rodríguez-Frade, J. M., Vila-Coro, A. J., Fernández, S., Martín de Ana, A., Jones, D. R., Torán, J. L. et al., Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J. 2001. 20: 2497-2507.
47. Baneres, J. L. and Parello, J., Structure-based analysis of GPCR function: Evidence for a novel pentameric assembly between the dimeric leukotriene B4 receptor BLT1 and the G-protein. J. Mol. Biol. 2003. 329: 815-829.
48. Blanpain, C., Vanderwinden, J. M., Cihak, J., Wittamer, V., Le Poul, E., Issafras, H., Stangassinger, M. et al., Multiple active states and oligomerization of CCR5 revealed by functional properties of monoclonal antibodies. Mol. Biol. Cell 2002. 13: 723-737.
49. Chen, X., Geller, E. B., Rogers, T. J. and Adler, M. W., Rapid heterologous desensitization of antinociceptive activity between mu or delta opioid receptors and chemokine receptors in rats. Drug. Alcohol Depend. 2007. 88: S71-84.
50. Szabo, I., Chen, X. H., Xin, L., Adler, M. W., Howard, O. M., Oppenheim, J. J. and Rogers, T. J., Heterologous desensitization of opioid receptors by chemokines inhibits chemotaxis and enhances the perception of pain. Proc. Natl. Acad. Sci. USA 2002. 99:10276-10281
51. Babcock, G. J., Farzan, M. and Sodroski, J., Ligand-independent dimerization of CXCR4, a principal HIV-1 coreceptor. J. Biol. Chem. 2003. 278: 3378-3385.
52. Rodríguez-Frade, J. M., del Real, G., Serrano, A., Hernanz-Falcón, P., Soriano, S. F., Vila-Coro, A. J., de Ana, A.M. et al. Blocking HIV-1 infection via CCR5 and CXCR4 receptors by acting in trans on the CCR2 chemokine receptor. EMBO J. 2004. 23: 66-76.
53. Mellado, M., Rodriguez-Frade, J. M., Aragay, A., del Real, G., Martin, A. M., Vila-Coro, A. J., Serrano, A. et al., The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor. J. Immunol. 1998. 161: 805-813.
54. Ropero, S., Chiloeches, A., Montes, A. and Toro-Nozal, M. J., Cholesterol cell content modulates GTPase activity of G proteins in GH4C1 cell membranes. Cell Signal. 2003. 15: 131-138.
55. Poncelet, P. G. and Lavabre-Bertrand, T., Immunological detection of membrane-bound antigens and receptors. In: Masseyeff, R. F., Albert, W. H. and Staines, N. A. (Eds.), Methods of Immunological Analysis. VCH, Weinheim, Germany 1993, pp. 388-418.